The down-regulation of FBL in severe patients of COVID-19 with 50% lethality frequency was shown to play pivotal roles in impairing ribosome function and in cell cycle arrest, maximizing the transcription and translation of the SARS-CoV-2 genes while decreasing the production of host genes. This evidence concerns the gene FBL and COVID-19.